Title
Diagnosis and Treatment of Acute and Chronic Heart Failure
Authoring Organization
Publication Month/Year
August 25, 2023
Last Updated Month/Year
August 29, 2023
Supplemental Implementation Tools
Document Type
Guideline
Country of Publication
European
Document Objectives
Since the publication of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, there have been several randomized controlled trials that should change patient management ahead of the next scheduled full guideline. This 2023 Focused Update addresses changes in recommendations for the treatment of HF because of this new evidence. We considered new published evidence up until the 31 March 2023. After considering and discussing many new major randomized controlled clinical trials and meta-analyses, the Task Force voted to include those that would lead to Class IIa and I recommendations. This has led to us updating some of our guidance for the treatment of HFmrEF, HFpEF, comorbidities and Acute HF.
Inclusion Criteria
Male, Female, Adult, Older adult
Health Care Settings
Ambulatory, Hospital, Outpatient
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Diagnosis, Treatment, Management
Diseases/Conditions (MeSH)
D006333 - Heart Failure
Keywords
heart failure, acute heart failure
Source Citation
Theresa A McDonagh and others, 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC, European Heart Journal, 2023;, ehad195, https://doi.org/10.1093/eurheartj/ehad195